Showing results (91-100 of 152) with videos related to
Sort By:
Pageof 16
Pharmacy (Basel, Switzerland)|March 24, 2026
Real-World Comparison of Intravenous vs. Oral Antimicrobial Therapy for Bone and Joint InfectionsMaura Kreiser, Sarah Al Mansi, Ismaeel Yunusa, et al.Pharmacotherapy|March 19, 2025
A review of antibiotic safety in pregnancy-2025 updateJohny Nguyen, Victoria Madonia, Christopher M Bland, et al.Hospital Pharmacy|December 26, 2017
Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local EvidenceElizabeth B Nimmich, P Brandon Bookstaver, Joseph Kohn, et al.Infection Control and Hospital Epidemiology|December 20, 2016
Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream IsolatesMatthew R Augustine, Traci L Testerman, Julie Ann Justo, et al.Therapeutic Advances in Infectious Disease|October 23, 2024
The top 10 papers on the treatment of invasive fungal infections, 2018-2023Kayla R Stover, Harleigh M Aldridge, Katherine L Pollan, et al.Journal of Central Nervous System Disease|June 6, 2017
Management of Viral Central Nervous System Infections: A Primer for CliniciansP Brandon Bookstaver, Phillip L Mohorn, Ansal Shah, et al.The Annals of Pharmacotherapy|December 18, 2018
Common Bacterial and Viral Infections: Review of Management in the Pregnant PatientHana Rac, Alyssa P Gould, Lea S Eiland, et al.Pharmacotherapy|May 29, 2013
Safety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the southeastern United StatesP Brandon Bookstaver, Christopher M Bland, Zaina P Qureshi, et al.International Journal of Antimicrobial Agents|September 12, 2020
Use of continuous-infusion ceftolozane/tazobactam for resistant Gram-negative bacterial infections: a retrospective analysis and brief review of the literatureMary Sheffield, Dana Nelson, Melissa O'Neal, et al.Pharmacy (Basel, Switzerland)|January 25, 2022
Clinical Utility and Cost Effectiveness of Long-Acting Lipoglycopeptides Used in Deep-Seated Infections among Patients with Social and Economic Barriers to CareKayla Antosz, Majdi N Al-Hasan, Z Kevin Lu, et al.Pageof 16